The MMRF Blog
DECEMBER 19, 2014
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.
Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG. Lancet Oncol. 2014 Dec;15(13):1503-12. doi: 10.1016/S1470-2045(14)71125-8. Epub 2014 Nov 14.
PMID: 25456369 [PubMed - in process]
Posted: December 19, 2014
DECEMBER 17, 2014
We are so excited to announce that the MMRF has been listed by Consumer Reports as one of the highest-rated charities for the cancer cause. The report on www.consumerreports.org came out right in the middle of one of the most charitable seasons, and warns against giving to a charity without first doing a little homework. READ MORE
Posted: December 17, 2014
NOVEMBER 25, 2014
Barlogie B, Mitchell A, van Rhee F, Epstein J, Morgan GJ, Crowley J.
Blood. 2014 Nov 13;124(20):3043-51. doi: 10.1182/blood-2014-07-552059. Epub 2014 Oct 7.
PMID: 25293776 [PubMed - in process]
Posted: November 25, 2014